Skip to main content
. 2019 Nov 6;29(1):e13185. doi: 10.1111/ecc.13185

Table 6.

Time investment

Polypharmacy assessment phase Mean time spent per patient in min (range)
Preparation, collecting relevant data (n = 60) 15 (5–30)
Geriatric assessment (n = 34) 10 (10–10)
Polypharmacy anamnesis (n = 60) 24 (10–45)
Polypharmacy analysis and providing treatment plan to oncologist/haematologist (n = 60) 22 (5–50)
Total 71 (40–120)